Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease
Ehrin J. Armstrong(VA Eastern Colorado Health Care System), John R. Laird(University of California Davis Medical Center), Gagan D. Singh(University of California, Davis), Heejung Bang(University of California, Davis), Ezra A. Amsterdam(University of California Davis Medical Center), Khung Keong Yeo(SingHealth), Julie A. Freischlag(University of California, Davis), David R. Anderson(Dalhousie University)
Cited by 75
Related Papers
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
|Blood Advances|2019|586
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
|The Lancet|2013|522
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism
|CHEST Journal|2016|275
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243